Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide is associated with suppression of nuclear transcription factor kappa B

Biology of the Neonate

Volumn 87, Issue 2, 2005, Pages 73-81

  Hu, Xiaowei ^a   Cao, Lei ^a   Lam, Li Kuei ^a   Zhu, Liewei ^a   Guo, Chunbao ^a   Sun, Bo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Meconium induced lung injury; Nitric oxide; Nuclear transcription factor kappa B; Pulmonary surfactant; Respiratory failure

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID DERIVATIVE; PROTEIN; SURFACTANT;

AERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; FEMALE; HYPOXEMIA; LUNG INJURY; LUNG LAVAGE; LUNG MECHANICS; LUNG MODEL; LUNG PARENCHYMA; LUNG WEIGHT; MALE; MECONIUM ASPIRATION; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RESPIRATORY FAILURE; SURFACE TENSION;

ANIMALS; ANOXEMIA; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; HUMANS; INFANT, NEWBORN; LUNG; LUNG DISEASES; MECONIUM ASPIRATION SYNDROME; NF-KAPPA B; NITRIC OXIDE; PHOSPHATIDYLCHOLINES; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; RABBITS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 14044271463     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081266     Document Type: Article

References (30)

1. American Academy of Pediatrics, Committee on Fetus and Newborn: Use of inhaled nitric oxide. Pediatrics 2000;106(2 Pt 1):344-345.
2. The Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
3. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP: Low-dose nitric oxide therapy for persistent pulmonary hypertension. N Engl J Med 2000;342:469-474.
4. Jacobs P, Finer NN, Robertson CM, Etches P, Hall EM, Saunders LD: A cost-effectiveness analysis of the application of nitric oxide versus oxygen gas for near-term newborns with respiratory failure: Results from a Canadian randomized clinical trial. Crit Care Med 2000;28:872-878.
5. Sun B, Curstedt T, Robertson B: Surfactant inhibition in experimental meconium aspiration. Acta Paediatr 1993;82:182-189.
6. de Beaufort AJ, Bakker AC, van Tol MJ, Poorthuis BJ, Schrama AJ, Berger HM: Meconium is a source of pro-inflammatory substances and can induce cytokine production in cultured A549 epithelial cells. Pediatr Res 2003;54:491-495.
7. Li YH, Yan ZQ, Brauner A, Tullus K: Meconium induces expression of inducible NO synthase and activation of NF-κB in rat alveolar macrophages. Pediatr Res 2001;49:820-825.
8. LeVine AM, Lotze A, Stanley S, Stroud C, O'Donnell R, Whitsett J, Pollack MM: Surfactant content in children with inflammatory lung disease. Crit Care Med 1996;24:1062-1067.
9. Luchetti M, Ferrero F, Gallini C, Natale A, Pigna A, Tortorolo L, Marraro G: Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med 2002;3:261-268.
10. Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B, members of the Collaborative European Multicenter Study Group: Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Pediatrics 2000;106:957-964.
11. Baur FM, Brenner B, Goetze-Speer B, Neu S, Speer CP: Natural porcine surfactant (Curosurf) down-regulates mRNA of tumor necrosis factor-α (TNF-α) and TNF-α type II receptor in lipopolysaccharide-stimulated monocytes. Pediatr Res 1998;44:32-36.
12. Antal JM, Divis LT, Erzurum SC, Wiedemann HP, Thomassen MJ: Surfactant suppresses NF-kappa B activation in human monocytic cells. Am J Respir Cell Mol Biol 1996;14:374-379.
13. Rais-Bahrami K, Rivera O, Seale WR, Short BL: Effect of nitric oxide in meconium aspiration syndrome after treatment with surfactant. Crit Care Med 1997;25:1744-1747.
14. Zhu GF, Sun B, Niu SF, Lin K, Lindwall R, Robertson B: Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:437-443.
15. Zhou ZH, Sun B, Lin K, Zhu LW: Prevention of rabbit acute lung injury by surfactant, inhaled nitric oxide, and pressure support ventilation. Am J Respir Crit Care Med 2000;161(2 Pt 1):581-588.
16. Sison C, Bry K, Sephus J, Hallman M: Effects of inhaled nitric oxide and surfactant treatment on lung function and pulmonary hemodynamics in bronchoalveolar-lavage-induced respiratory failure. Pediatr Pulmonol 2000;29:202-209.
17. Huang QW, Sun B, Gao F, Zhang Y, Wu Y, Zhu LW, Lindwall R: Effects of inhaled nitric oxide and high-frequency ventilation in rabbits with meconium aspiration. Biol Neonate 1999;76:374-382.
18. Hegesh E, Gruener N, Cohen S, Bochkovsky R, Shuval HI: A sensitive micromethod for the determination of methemoglobin in blood. Clin Chim Acta 1970;30:679-682.
19. Mason RJ, Nellenbogen J, Clements JA: Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976;17:281-284.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
21. Ennema JJ, Kobayashi T, Robertson B, Curstedt T: Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia. Acta Anaesthesiol Scand 1988;32:665-671.
22. Held HD, Boettcher S, Hamann L, Uhlig S: Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-κB and is blocked by steroids. Am J Respir Crit Care Med 2001;163(3 Pt 1):711-716.
23. Blackwell TS, Lancaster LH, Blackwell TR, Venkatakrishnan A, Christman JW: Differential NF-κB activation after intratracheal endotoxin. Am J Physiol 1999;277(4 Pt 1):L823-L830.
24. Gessler P, Nebe T, Birle A, Mueller W, Kachel W: A new side effect of inhaled nitric oxide in neonates and infants with pulmonary hypertension: Functional impairment of the neutrophil respiratory burst. Intensive Care Med 1996;22:252-258.
25. Kinsella JP, Parker TA, Galan H, Sheridan BC, Helbower AC, Abman SH: Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 1997;41(4 Pt 1):457-463.
26. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P: Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 2003;349:2099-2107.
27. Cao L, Liu C, Cai B, Jia X, Kang L, Speer CP, Sun B: Nuclear factor-kappa B expression in alveolar macrophages of mechanically ventilated neonates with respiratory distress syndrome. Biol Neonate 2004;86:116-123.
28. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev Immunol 1996;14:649-683.
29. Cao L, Qian LL, Zhu YR, Guo CB, Gong XH, Sun B: Regulation of activity of nuclear factor-kB and activator protein-1 by nitric oxide, surfactant and glucocorticoids in alveolar macrophages from piglets with acute lung injury. Acta Pharmacol Sin 2003;24:1316-1323.
30. Sun B, Curstedt T, Song GW, Robertson B: Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. Biol Neonate 1993;63:96-104.